Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Protokinetix Inc (QB) | PKTX | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0139 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.0101 - 0.03 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.0139 | USD |
Protokinetix Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.39M | 335.63M | - | 0 | -415k | -0.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Protokinetix (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PKTX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0142 | 0.0153 | 0.0112 | 0.0136255 | 67,278 | -0.0003 | -2.11% |
1 Month | 0.0164 | 0.0167 | 0.0112 | 0.0142277 | 67,529 | -0.0025 | -15.24% |
3 Months | 0.016 | 0.0199 | 0.0112 | 0.0159805 | 118,837 | -0.0021 | -13.13% |
6 Months | 0.023125 | 0.0289 | 0.0102 | 0.0173174 | 126,247 | -0.00923 | -39.89% |
1 Year | 0.0262 | 0.03 | 0.0101 | 0.0193171 | 106,854 | -0.0123 | -46.95% |
3 Years | 0.1302 | 0.1888 | 0.0101 | 0.0414558 | 83,229 | -0.1163 | -89.32% |
5 Years | 0.16 | 0.32 | 0.0101 | 0.0995397 | 92,203 | -0.1461 | -91.31% |
Protokinetix (QB) Description
ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever. |